Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Editas Medicine (EDIT) over the last 6 years, with Dec 2024 value amounting to $82.3 million.

  • Editas Medicine's Shares Outstanding (Diluted Average) rose 9.22% to $90.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.1 million, marking a year-over-year increase of 9.22%. This contributed to the annual value of $82.3 million for FY2024, which is 8.39% up from last year.
  • Per Editas Medicine's latest filing, its Shares Outstanding (Diluted Average) stood at $82.3 million for FY2024, which was up 8.39% from $76.0 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Shares Outstanding (Diluted Average) ranged from a high of $82.3 million in FY2024 and a low of $58.6 million during FY2020.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $75.7 million, with a median of $76.0 million in 2023.
  • Data for Editas Medicine's Shares Outstanding (Diluted Average) shows a peak YoY climbed of 17.26% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Editas Medicine's Shares Outstanding (Diluted Average) stood at $58.6 million in 2020, then grew by 15.37% to $67.6 million in 2021, then rose by 1.55% to $68.7 million in 2022, then grew by 10.63% to $76.0 million in 2023, then climbed by 8.39% to $82.3 million in 2024.